" class="no-js "lang="en-US"> Hyland Healthcare - Medtech Alert
Thursday, March 30, 2023

Breaking News

Nanoscope Therapeutics Announces Positive Topline Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics Mathai Mammen to Join FogPharma as Chairman, President and Chief Executive Officer Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases Implantica Launches RefluxStop™ in Italy Granular Therapeutics to Accelerate Development of Next-Generation Pipeline for Treating Mast Cell Driven Diseases Xeris Biopharma Appoints Ricki Fairley to Board of Directors AskBio to Present Phase 1b Results Investigating AB-1005 as Treatment for Parkinson’s Disease New Imaging Method for Evaluating Transport of Oxygen to Blood Cells
Hyland Healthcare | Pharmtech Focus

Hyland Healthcare

About Hyland Healthcare

Hyland Healthcare

Hyland is a leading content services provider that enables thousands of organizations to deliver better experiences to the people they serve. With more than 4,000 employees around the world, Hyland is widely known as both a great company to work for and a great company to do business with.

Related Story

Industry News

 Gloucestershire Hospitals NHS Foundation Trust Selects Hyland Healthcare for Enhanced Content Services Infrastructure | Pharmtech Focus

Gloucestershire Hospitals NHS Foundation Trust Selects Hyland Healthcare for Enhanced Content Services Infrastructure

September 15 2021

NHS Digital Aspirant Gloucestershire Hospitals NHS Foundation Trust (GHNHSFT) is moving a core element of its […]